Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
about
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisFighting the Monster: Applying the Host Damage Framework to Human Central Nervous System InfectionsPrimary Progressive Multiple Sclerosis: Putting Together the PuzzlePioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes.Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosisIncreased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study.A Prospective Evaluation of Systemic Biomarkers and Cognitive Function Associated with Carotid Revascularization.Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults.Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.Choroid Plexitis and Ependymitis by Magnetic Resonance Imaging are Biomarkers of Neuronal Damage and Inflammation in HIV-negative Cryptococcal Meningoencephalitis.Pharmacodynamic effects of daclizumab in the intrathecal compartment.Autologous Bone Marrow Transplantation in Multiple Sclerosis: Biomarker Relevance for Patient Recruitment and Follow up.New Multiple Sclerosis Disease Severity Scale Predicts Future Accumulation of Disability.The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple Sclerosis.Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic.Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments.Molecular-based diagnosis of multiple sclerosis and its progressive stage.Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping.Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.
P2860
Q26740330-17F24321-61C7-4A99-A037-6F615E99D6C6Q26774211-802160CB-8703-474D-8A48-D4CA8B88C6A7Q33365606-EB15ED78-768D-4536-A381-7BA10A8AE1B6Q36410286-78D56F99-F5E6-43ED-BD51-6616ED803B3CQ36639659-8942E5E2-4421-4FC1-8D01-758C39EB3D3CQ37655201-10BFA1C6-4FD3-41D3-8499-595921AFB163Q37696944-108B7490-A07A-4346-9169-6551AEF413BDQ39067727-7CC2D60E-C521-40BD-BEA0-596F091975DDQ39119839-887DE189-D071-4246-AA82-6F355F18D788Q40072853-ACBF059D-1FBC-48C2-AEB7-607C37217DDEQ40962441-351FC39C-5590-4441-87AF-79AF630E263FQ41236543-41FF4CD3-9BB8-4FA9-A037-07F76A92917BQ45974017-5849DDB3-5A7D-4647-88C9-4B00C7DE617DQ47109739-166F1A2C-2395-4141-81D2-4B74F6DD3414Q47117780-31A20FD9-AFDB-4D24-A907-CF15F4602CBDQ47134235-89B5737D-0BD4-45BB-90F2-33471E48BCB8Q47200732-838377FE-2C4F-4B17-913E-3BDB25C1E9BEQ47615874-E2AB1956-65B7-4E9F-AADB-5FF7E09C0667Q47657261-1101451D-395A-4399-986F-70582C15FEF7Q48132838-373EE0A2-492B-4E32-BC36-4937498233B9Q52688331-E3B06FB8-27C8-4CF9-B954-5091605A050CQ53397201-F7F04575-491D-4EDC-80A8-69AD2F4137E8
P2860
Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cerebrospinal fluid markers re ...... rogressive multiple sclerosis.
@en
Cerebrospinal fluid markers re ...... rogressive multiple sclerosis.
@nl
type
label
Cerebrospinal fluid markers re ...... rogressive multiple sclerosis.
@en
Cerebrospinal fluid markers re ...... rogressive multiple sclerosis.
@nl
prefLabel
Cerebrospinal fluid markers re ...... rogressive multiple sclerosis.
@en
Cerebrospinal fluid markers re ...... rogressive multiple sclerosis.
@nl
P2093
P2860
P921
P356
P1433
P1476
Cerebrospinal fluid markers re ...... progressive multiple sclerosis
@en
P2093
Andrew Blake
Anil A Panackal
Bibiana Bielekova
Elena Romm
Mark Greenwood
Mika Komori
Muktha Natrajan
Paige Winokur
Peter Kosa
Peter R Williamson
P2860
P356
10.1002/ANA.24408
P577
2015-04-16T00:00:00Z